DOI: 10.1093/infdis/jiad531 ISSN: 0022-1899

Healthcare Personnel Exposure Risk Assessment and Management During a Mpox Outbreak in Chicago, Illinois, May 17-July 8, 2022

Shane Zelencik, Alison VanDine, Maria Campos-Bovee, Kimberly Goitia, Valbona Cela, Kelly Walblay, Daniel Galanto, Massimo Pacilli, Do Young Kim, Stephanie R Black
  • Infectious Diseases
  • Immunology and Allergy

Abstract

This report summarizes risk assessment interviews and follow up with healthcare personnel (HCP) after exposure to patients with mpox disease during May 17-July 8, 2022. HCP-case interactions were assessed using a standard questionnaire to categorize the risk associated with patient encounters. We assessed 150 interactions among 142 HCP and 30 cases. Four(2.7%) interactions were defined as high risk, 5(3.3%) intermediate, 107(71.3%) low, and 31(20.7%) no risk. High and intermediate exposures were offered post-exposure prophylaxis; four accepted. No documented mpox transmission after exposure was identified. These findings suggest transmission risk in healthcare settings during routine patient care is low.

More from our Archive